Description
Vía de administración: Inhalación por nebulización
Tumores del estroma gastrointestinal (GIST) después del fracaso de imatinib y sunitinib
300/250 MG
FABRICANTE: PISA
Uso exclusivo bajo estricta supervisión médica
CRA PONDS CLAR B3 FPS15 T100 LAURET SULFATO DE SODIO Vía de administración: Inhalación porDOSIS: 100 G FORMA FARMACUTICA: 1 CREMA CORPORAL PRESENTACIN: 1 ENVASE
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
